ResearcherHarbin Medical UniversityActive in the last 2 years
Kexin Li
Matched on ORCID iD 0009-0001-7193-0534; OpenAlex author ID A5100329683. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmace… Co-author DOI 10.3390/pharmaceutics18070808↗
- The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes. First author DOI 10.1038/s41598-023-41835-6↗
- Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15204917↗
- Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/pharmaceutics15102447↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Melissa L. Fishel · 4 shared papers, 2023–2026 · strength 0.90
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447↗
- Paper Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15204917↗
- Qingji Huo · 4 shared papers, 2023–2026 · strength 0.90
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447↗
- Paper Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15204917↗
- Hiroki Yokota · 4 shared papers, 2023–2026 · strength 0.90
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447↗
- Paper Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15204917↗
- Chang-peng Cui · 2 shared papers, 2023–2026 · strength 0.54
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447↗
- Kazuhiko Ogawa · 2 shared papers, 2023 · strength 0.36
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.